In the Press
David Fyfield has written for Life Sciences Intellectual Property Review on the Supreme Court's ruling in Regeneron Pharmaceuticals Inc v Kymab Ltd. Read more below (subscription required).
How patents for transgenic mice got caught in a sufficiency trap
Charles Russell Speechlys advises Management Refined Limited on the sale of its wholly owned subsidiary Meganexus Limited to NEC Software Solutions UK
Ashwin Pillay
News
Charles Russell Speechlys advises Qareeb Data Centres on strategic partnership to deliver Bahrain’s first edge data centre
Reem Al Mahroos
News
Infosecurity Magazine quotes Mark Bailey on the Cyber Security and Resilience Bill
Mark Bailey
In the Press
Law 360 quotes Caroline Greenwell and Bella Henry on the Santander APP fraud case
Caroline Greenwell
In the Press
New Cryptoasset Reporting Framework (CARF) implemented - how might it affect you?
Vadim Romanoff
Quick Reads
Digital Markets, Competition and Consumers Act 2024 (DMCCA): What the UK’s new consumer rules now mean for consumer facing businesses
Mark Dewar
Insights
Charles Russell Speechlys advises longstanding client Puma Growth Partners on its investment in HubBox
Ashwin Pillay
News
UAE CCL Reforms: Introducing Multi-Class Shares, Drag / Tag Rights, Deadlock Solutions and Governance Continuity
Mo Nawash
Quick Reads
Dewdney Drew writes for the AI Journal on AI actors and the legal hurdles facing a digital revolution
Dewdney William Drew
In the Press
AI and Employment Law: Fairness, Transparency and Workplace Risk
Emily Chalkley
Insights
Artificial Intelligence in M&A: Efficiency, Due Diligence and Risk Management
Daniel Rosenberg
Insights